343 results in Exploration of Targeted Anti-tumor Therapy
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Retraction
Retraction: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Editorial Office
Published: October 28, 2025 Explor Target Antitumor Ther. 2025;6:1002343
79 6 0
Open Access Original Article
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
Paweł Kochany ... Frank A.E. Kruyt
Published: October 28, 2025 Explor Target Antitumor Ther. 2025;6:1002342
117 12 0
Open Access Review
New approaches of green silver nanoparticles for cancer and biomedical applications: a review
Puja Kumari ... Md Sabir Alam
Published: October 23, 2025 Explor Target Antitumor Ther. 2025;6:1002341
441 31 0
Open Access Original Article
Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic nanoparticles for the treatment of colorectal cancer
Ritika Puri, Vimal Arora
Published: October 20, 2025 Explor Target Antitumor Ther. 2025;6:1002340
325 16 0
Open Access Review
Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress
Heayyean Lee ... Jeehoo Lee
Published: October 12, 2025 Explor Target Antitumor Ther. 2025;6:1002339
656 12 0
Open Access Review
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy
Anu Shibi Anilkumar ... Ramakrishnan Veerabathiran
Published: September 25, 2025 Explor Target Antitumor Ther. 2025;6:1002338
This article belongs to the special issue Cancer Vaccines: From Basic Innovations to Clinical Translation
555 21 0
Open Access Review
Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Mariam Rojas ... Joan Maurel
Published: September 23, 2025 Explor Target Antitumor Ther. 2025;6:1002337
657 21 0
Open Access Review
Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics
Shishir Singh ... Atar Singh Kushwah
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002335
This article belongs to the special issue Advances in Cancer Genomics and Therapeutic Targets
1391 30 0
Open Access Review
Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact
Yuting Sheng ... Yujiang Fang
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002334
971 21 0
Open Access Review
Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives
Ekaterina S. Kuligina ... Evgeny N. Imyanitov
Published: August 08, 2025 Explor Target Antitumor Ther. 2025;6:1002333
4315 106 0
Open Access Original Article
Retracted: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Rolla Al-Shalabi ... Nozlena Abdul Samad
Published: July 27, 2025 Explor Target Antitumor Ther. 2025;6:1002332
1987 64 0
Open Access Original Article
Novel kinase-activating genetic events in non-small cell lung carcinomas
Elena V. Preobrazhenskaya ... Evgeny N. Imyanitov
Published: July 09, 2025 Explor Target Antitumor Ther. 2025;6:1002330
1153 15 0
Open Access Review
Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives
Gurkaranjot Singh ... Vikrant Rai
Published: June 27, 2025 Explor Target Antitumor Ther. 2025;6:1002329
2423 36 5
Open Access Review
Biliary tract cancers: advances in diagnostic and management
James Gutmans, Hiba Mechahougui
Published: June 23, 2025 Explor Target Antitumor Ther. 2025;6:1002328
1848 32 0
Open Access Perspective
Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy
Ilya Tsimafeyeu
Published: June 20, 2025 Explor Target Antitumor Ther. 2025;6:1002327
3667 48 0
Open Access Review
An overview of the feasibility of nanomedicine in pancreatic cancer theranostics
Kyriakos Kokkinogoulis ... Mersini Makropoulou
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002326
1585 18 1
Open Access Original Article
Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
Anna Sokolenko ... Evgeny Imyanitov
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002325
1182 10 0
Open Access Review
Osteosarcoma: current insights and advances
Guraustin S. Brar ... Yujiang Fang
Published: June 15, 2025 Explor Target Antitumor Ther. 2025;6:1002324
1904 41 2